ReviewFrontiers in immunology2025

Immunogenicity risk assessment for tailored mitigation and monitoring of biotherapeutics during development: recommendations from the European Immunogenicity Platform.

Joanna Grudzinska-Goebel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.